-
Communities
-
Explore Vanderbilt communities
By latest
Featured community
Creative Data Solutions (CDS) is a Vanderbilt Shared Resource and has extensive experience in providing effective and robust solutions to challenges pertaining to research data using modern informatics and bioinformatics approaches.
-
- Resources
-
People
-
Publications
-
Explore publications
-
Keyword Connections
Connections to Influenza A Virus, H1N1 Subtype are shown below. Double-click or tap a node for more information.
Please note that publication matches are limited to 40 in this view. If you expected more, please view all publication matches for Influenza A Virus, H1N1 Subtype.
Members
- No matching connections
Resources
- No matching connections
Communities
- No matching connections
Publications
- Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors.
Yu X, Tsibane T, McGraw PA, House FS, Keefer CJ, Hicar MD, Tumpey TM, Pappas C, Perrone LA, Martinez O, Stevens J, Wilson IA, Aguilar PV, Altschuler EL, Basler CF, Crowe JE
(2008) Nature 455: 532-6 - Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus.
Xu R, Ekiert DC, Krause JC, Hai R, Crowe JE, Wilson IA
(2010) Science 328: 357-60 - Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes.
Monsalvo AC, Batalle JP, Lopez MF, Krause JC, Klemenc J, Hernandez JZ, Maskin B, Bugna J, Rubinstein C, Aguilar L, Dalurzo L, Libster R, Savy V, Baumeister E, Aguilar L, Cabral G, Font J, Solari L, Weller KP, Johnson J, Echavarria M, Edwards KM, Chappell JD, Crowe JE, Williams JV, Melendi GA, Polack FP
(2011) Nat Med 17: 195-9 - Viral acute lower respiratory infections impair CD8+ T cells through PD-1.
Erickson JJ, Gilchuk P, Hastings AK, Tollefson SJ, Johnson M, Downing MB, Boyd KL, Johnson JE, Kim AS, Joyce S, Williams JV
(2012) J Clin Invest 122: 2967-82 - Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia.
McAuley JL, Hornung F, Boyd KL, Smith AM, McKeon R, Bennink J, Yewdell JW, McCullers JA
(2007) Cell Host Microbe 2: 240-9 - Glycan shielding of the influenza virus hemagglutinin contributes to immunopathology in mice.
Wanzeck K, Boyd KL, McCullers JA
(2011) Am J Respir Crit Care Med 183: 767-73 - HLA targeting efficiency correlates with human T-cell response magnitude and with mortality from influenza A infection.
Hertz T, Oshansky CM, Roddam PL, DeVincenzo JP, Caniza MA, Jojic N, Mallal S, Phillips E, James I, Halloran ME, Thomas PG, Corey L
(2013) Proc Natl Acad Sci U S A 110: 13492-7 - Influenza Vaccine Effectiveness for Prevention of Severe Influenza-Associated Illness Among Adults in the United States, 2019-2020: A Test-Negative Study.
Grijalva CG, Feldstein LR, Talbot HK, Aboodi M, Baughman AH, Brown SM, Casey JD, Erickson HL, Exline MC, Files DC, Gibbs KW, Ginde AA, Gong MN, Halasa N, Khan A, Lindsell CJ, Nwosu SK, Peltan ID, Prekker ME, Rice TW, Shapiro NI, Steingrub JS, Stubblefield WB, Tenforde MW, Patel MM, Self WH, Influenza and Other Viruses in the Acutely Ill (IVY) Network
(2021) Clin Infect Dis 73: 1459-1468 - Use of intravenous zanamivir after development of oseltamivir resistance in a critically Ill immunosuppressed child infected with 2009 pandemic influenza A (H1N1) virus.
Dulek DE, Williams JV, Creech CB, Schulert AK, Frangoul HA, Domm J, Denison MR, Chappell JD
(2010) Clin Infect Dis 50: 1493-6 - Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States.
Rice TW, Rubinson L, Uyeki TM, Vaughn FL, John BB, Miller RR, Higgs E, Randolph AG, Smoot BE, Thompson BT, NHLBI ARDS Network
(2012) Crit Care Med 40: 1487-98 - Emergency department visits for influenza A(H1N1)pdm09, Davidson County, Tennessee, USA.
Self WH, Grijalva CG, Zhu Y, Talbot HK, Jules A, Widmer KE, Edwards KM, Williams JV, Shay DK, Griffin MR
(2012) Emerg Infect Dis 18: 863-5 - Impact of body mass index on immunogenicity of pandemic H1N1 vaccine in children and adults.
Callahan ST, Wolff M, Hill HR, Edwards KM, NIAID Vaccine and Treatment Evaluation Unit (VTEU) Pandemic H1N1 Vaccine Study Group
(2014) J Infect Dis 210: 1270-4 - An insertion mutation that distorts antibody binding site architecture enhances function of a human antibody.
Krause JC, Ekiert DC, Tumpey TM, Smith PB, Wilson IA, Crowe JE
(2011) mBio 2: e00345-10 - Epitope-specific human influenza antibody repertoires diversify by B cell intraclonal sequence divergence and interclonal convergence.
Krause JC, Tsibane T, Tumpey TM, Huffman CJ, Briney BS, Smith SA, Basler CF, Crowe JE
(2011) J Immunol 187: 3704-11 - The burden of influenza in young children, 2004-2009.
Poehling KA, Edwards KM, Griffin MR, Szilagyi PG, Staat MA, Iwane MK, Snively BM, Suerken CK, Hall CB, Weinberg GA, Chaves SS, Zhu Y, McNeal MM, Bridges CB
(2013) Pediatrics 131: 207-16 - Antibody recognition of the pandemic H1N1 Influenza virus hemagglutinin receptor binding site.
Hong M, Lee PS, Hoffman RM, Zhu X, Krause JC, Laursen NS, Yoon SI, Song L, Tussey L, Crowe JE, Ward AB, Wilson IA
(2013) J Virol 87: 12471-80 - Influenza viruses with receptor-binding N1 neuraminidases occur sporadically in several lineages and show no attenuation in cell culture or mice.
Hooper KA, Crowe JE, Bloom JD
(2015) J Virol 89: 3737-45 - Naturally occurring human monoclonal antibodies neutralize both 1918 and 2009 pandemic influenza A (H1N1) viruses.
Krause JC, Tumpey TM, Huffman CJ, McGraw PA, Pearce MB, Tsibane T, Hai R, Basler CF, Crowe JE
(2010) J Virol 84: 3127-30 - Sotalol-induced torsades de pointes precipitated during treatment with oseltamivir for H1N1 influenza.
Wells Q, Hardin B, Raj SR, Darbar D
(2010) Heart Rhythm 7: 1454-7 - Phospholipase D facilitates efficient entry of influenza virus, allowing escape from innate immune inhibition.
Oguin TH, Sharma S, Stuart AD, Duan S, Scott SA, Jones CK, Daniels JS, Lindsley CW, Thomas PG, Brown HA
(2014) J Biol Chem 289: 25405-17 - Bacterial sinusitis and otitis media following influenza virus infection in ferrets.
Peltola VT, Boyd KL, McAuley JL, Rehg JE, McCullers JA
(2006) Infect Immun 74: 2562-7 - The high burden of pneumonia on US emergency departments during the 2009 influenza pandemic.
Self WH, Griffin MR, Zhu Y, Dupont WD, Barrett TW, Grijalva CG
(2014) J Infect 68: 156-64 - Complex febrile seizures followed by complete recovery in an infant with high-titer 2009 pandemic influenza A (H1N1) virus infection.
O'Leary MF, Chappell JD, Stratton CW, Cronin RM, Taylor MB, Tang YW
(2010) J Clin Microbiol 48: 3803-5 - The immune profile associated with acute allergic asthma accelerates clearance of influenza virus.
Samarasinghe AE, Woolard SN, Boyd KL, Hoselton SA, Schuh JM, McCullers JA
(2014) Immunol Cell Biol 92: 449-59 - Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communities.
Griffin MR, Monto AS, Belongia EA, Treanor JJ, Chen Q, Chen J, Talbot HK, Ohmit SE, Coleman LA, Lofthus G, Petrie JG, Meece JK, Hall CB, Williams JV, Gargiullo P, Berman L, Shay DK, U.S. Flu-VE Network
(2011) PLoS One 6: e23085 - Clinical assessment of serious adverse events in children receiving 2009 H1N1 vaccination.
Pahud BA, Williams SE, Dekker CL, Halsey N, Larussa P, Baxter RP, Klein NP, Marchant CD, Sparks RC, Jakob K, Aukes L, Swope S, Barnett E, Lewis P, Berger M, Dreskin SC, Donofrio PD, Sejvar JJ, Slade BA, Gidudu J, Vellozzi C, Edwards KM
(2013) Pediatr Infect Dis J 32: 163-8 - H1N1 infection mimicking the clinical presentation of gastrointestinal GVHD in a patient following allo-SCT.
Frangoul H, Domm J, Denison MR, Calder C, Black J
(2011) Bone Marrow Transplant 46: 152-3 - Phase 2 assessment of the safety and immunogenicity of two inactivated pandemic monovalent H1N1 vaccines in adults as a component of the U.S. pandemic preparedness plan in 2009.
Chen WH, Winokur PL, Edwards KM, Jackson LA, Wald A, Walter EB, Noah DL, Wolff M, Kotloff KL, Pandemic H1N1 Vaccine Adult Study Group
(2012) Vaccine 30: 4240-8 - Vitamin D is not associated with serologic response to influenza vaccine in adults over 50 years old.
Sundaram ME, Talbot HK, Zhu Y, Griffin MR, Spencer S, Shay DK, Coleman LA
(2013) Vaccine 31: 2057-61 - Immediate hypersensitivity reactions following monovalent 2009 pandemic influenza A (H1N1) vaccines: reports to VAERS.
Halsey NA, Griffioen M, Dreskin SC, Dekker CL, Wood R, Sharma D, Jones JF, LaRussa PS, Garner J, Berger M, Proveaux T, Vellozzi C, Hypersensitivity Working Group of the Clinical Immunization Safety Assessment Network, Broder K, Setse R, Pahud B, Hrncir D, Choi H, Sparks R, Williams SE, Engler RJ, Gidudu J, Baxter R, Klein N, Edwards K, Cano M, Kelso JM
(2013) Vaccine 31: 6107-12 - International crises and global health electives: lessons for faculty and institutions.
Steiner BD, Carlough M, Dent G, Peña R, Morgan DR
(2010) Acad Med 85: 1560-3 - Seasonal maintenance of influenza vaccine-induced antibody response in kidney transplant recipients.
Birdwell KA, Ikizler MR, Wang L, Byrne DW, Sannella EC, Wright PF, Ikizler TA
(2012) Am J Nephrol 36: 201-7 - Seroprevalence of seasonal and pandemic influenza A viruses in domestic cats.
McCullers JA, Van De Velde LA, Schultz RD, Mitchell CG, Halford CR, Boyd KL, Schultz-Cherry S
(2011) Arch Virol 156: 117-20 - Pandemic influenza A(H1N1)pdm09: an unrecognized cause of mortality in children in Pakistan.
Ali SA, Aziz F, Akhtar N, Qureshi S, Edwards K, Zaidi A
(2013) Scand J Infect Dis 45: 791-5 - Estimating age-specific influenza-related hospitalization rates during the pandemic (H1N1) 2009 in Davidson Co, TN.
Jules A, Grijalva CG, Zhu Y, Talbot KH, Williams JV, Dupont WD, Edwards KM, Schaffner W, Shay DK, Griffin MR
(2012) Influenza Other Respir Viruses 6: e63-71 - Serological response to influenza vaccination among adults hospitalized with community-acquired pneumonia.
Pratt CQ, Zhu Y, Grijalva CG, Wunderink RG, Mark Courtney D, Waterer G, Levine MZ, Jefferson S, Self WH, Williams DJ, Finelli L, Bramley AM, Edwards KM, Jain S, Anderson EJ
(2019) Influenza Other Respir Viruses 13: 208-212
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.
